Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bristol-Myers Squibb
With
Pfizer
Age
0–18
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com
Participants with any stable disease that are at risk for a venous or arterial thrombotic disorder
Neonates ≥ 34 weeks gestational or ≥ 37 weeks post conceptual age (corrected gestational age) to \<18 years of age
* Gestational and post-conceptual age will only be taken into consideration for eligibility up to 6 months of age
* Neonates: defined as newly born (within 4 weeks)
Participants with any functional CVAD (Central Venous Access Device) in the upper or lower venous system
You may not be if
Current or recent (within 3 months of study drug administration) gastrointestinal disease or gastrointestinal surgery that, in the opinion of the investigator and the BMS Medical Monitor, could impact the absorption of the study drug
Active bleeding or high risk of bleeding
Inability to tolerate oral medication or administration of oral medication via an enteral tube (nasogastric tube \[NG tube\] or gastronomy tube \[G-tube\])
Clareo Health | Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder
